The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children.
OBJECTIVE
This study was done to determine whether the use of reference values obtained in children with idiopathic short stature (ISS) improved the clinical value of serum insulin-like growth factor I (IGF-1) as a tool for diagnosing GH deficiency (GHD) in prepubertal children.


METHODS
Serum IGF-1 was measured with a new IRMA kit (IGFI-RIA CT, Cis Bio, Gif sur Yvette, France) in 168 prepubertal normal children and in prepubertal children with ISS (n = 68), organic GHD due to a craniopharyngioma (oGHD, n = 15) and permanent idiopathic GHD (iGHD, n = 28).


RESULTS
IGF-1 was lower (P < 0.001) in iGHD than in either ISS or oGHD and was below the fifth percentile of the normal range in 29/68 ISS (43%), 8/15 oGHD (53%) and 28/28 (100%) iGHD patients. Three oGHD (20%) and two iGHD (7%) patients had a serum IGF-1 below the fifth percentile of the normal group but above the fifth percentile of the ISS group. Thus, a serum IGF-1 below the fifth percentile of the normal group distinguished between normal children and iGHD with 100% sensitivity, between normal and oGHD with 53% sensitivity and between normal and all GHD (idiopathic + organic) with 84% sensitivity; the overall specificity was only 57%. Conversely, a serum IGF-1 below the fifth percentile of the ISS population distinguished between ISS and iGHD with 93% sensitivity, between ISS and oGHD with 33% sensitivity and between ISS and all GHD with 72% sensitivity; the overall specificity was then 95%.


CONCLUSIONS
A serum IGF-1 within the normal range virtually excludes idiopathic GHD but does not rule out organic GHD, whereas an IGF-1 below the ISS range is strongly in favour of GHD, after exclusion of poor nutritional status and/or liver disease. An IGF-1 below the normal range but in the idiopathic short stature range gives no definitive conclusion even when it is associated with a low GH peak. Thus, whereas reference values obtained in normal children must be used to interpret serum IGF-1 in short prepubertal children, reference data obtained in idiopathic short stature children should also be taken into account.
Bussières
L
L
Department of Physiology, Hôpital Necker-Enfants Malades, Université R Descartes, Paris, France.
Souberbielle
J C
JC
Pinto
G
G
Adan
L
L
Noel
M
M
Brauner
R
R
D002648:Child; D002675:Child, Preschool; D003397:Craniopharyngioma / Q000097:blood* / Q000150:complications; D005260:Female; D006130:Growth Disorders / Q000097:blood* / Q000209:etiology; D013006:Growth Hormone / Q000097:blood / Q000172:deficiency*; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood* / Q000150:complications; D011237:Predictive Value of Tests; D012016:Reference Values; D012680:Sensitivity and Specificity
D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone